Canada markets close in 4 hours 22 minutes

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
64.55+1.76 (+2.80%)
As of 11:38AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close62.79
Open62.82
Bid64.51 x 300
Ask67.62 x 100
Day's Range62.71 - 65.61
52 Week Range62.07 - 87.87
Volume3,846,938
Avg. Volume6,980,798
Market Cap80.42B
Beta (5Y Monthly)0.22
PE Ratio (TTM)179.31
EPS (TTM)0.36
Earnings DateAug 08, 2024
Forward Dividend & Yield3.08 (4.85%)
Ex-Dividend DateJun 14, 2024
1y Target Est81.21
  • GuruFocus.com

    Gilead Sciences Inc's Dividend Analysis

    Gilead Sciences Inc (NASDAQ:GILD) recently announced a dividend of $0.77 per share, payable on 2024-06-27, with the ex-dividend date set for 2024-06-14. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Gilead Sciences Inc's dividend performance and assess its sustainability.

  • Business Wire

    New Kite Clinical Research and Real-World Evidence for Yescarta® Demonstrate Benefit From Earlier Lines of Treatment

    SANTA MONICA, Calif., June 14, 2024--Kite, a Gilead Company (Nasdaq: GILD), today announced results from three new analyses for Yescarta® (axicabtagene ciloleucel) in relapsed/refractory (R/R) large B-cell lymphoma (LBCL), including both new clinical research and real-world evidence highlighting manufacturing and product characteristics of Yescarta, and outpatient administration of both Yescarta and Tecartus® (brexucabtagene autoleucel) at the 2024 European Hematology Association (EHA) Annual Co

  • Zacks

    Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts

    The latest trading day saw Gilead Sciences (GILD) settling at $63.56, representing a -1.21% change from its previous close.